Savitha M. Rao

Array ( [id] => 8138707 [patent_doc_number] => 20120093892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE' [patent_app_type] => utility [patent_app_number] => 13/333837 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093892.pdf [firstpage_image] =>[orig_patent_app_number] => 13333837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464733 [patent_doc_number] => 20120269901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Methods and Compounds Useful to Induce Apoptosis in Cancer Cells' [patent_app_type] => utility [patent_app_number] => 13/329611 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8835 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13329611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429749 [patent_doc_number] => 20120251624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'NOVEL INHIBITORS OF ARACHIDONIC ACID FORMATION' [patent_app_type] => utility [patent_app_number] => 13/315359 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2213 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8609441 [patent_doc_number] => 20130014753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'METHOD FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/304630 [patent_app_country] => US [patent_app_date] => 2011-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8020 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043565 [patent_doc_number] => 20120071518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone' [patent_app_type] => utility [patent_app_number] => 13/303074 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8129 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071518.pdf [firstpage_image] =>[orig_patent_app_number] => 13303074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817387 [patent_doc_number] => 20120064007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/299969 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064007.pdf [firstpage_image] =>[orig_patent_app_number] => 13299969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452855 [patent_doc_number] => 20120263802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability' [patent_app_type] => utility [patent_app_number] => 13/294152 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6033 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278499 [patent_doc_number] => 20120172371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'FLUOROQUINOLONE DERIVATIVES OR SULFONAMIDE MOIETY-CONTAINING COMPOUNDS AS INHIBITORS OF TYROSYL-DNAPHOSPHODIESTERASE (TDP1)' [patent_app_type] => utility [patent_app_number] => 13/283282 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13358 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13283282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766086 [patent_doc_number] => 20120034184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => '4\'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION' [patent_app_type] => utility [patent_app_number] => 13/274743 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10565 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034184.pdf [firstpage_image] =>[orig_patent_app_number] => 13274743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095807 [patent_doc_number] => 20120083512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'PHARMACEUTICAL PRODUCT FOR INJECTION' [patent_app_type] => utility [patent_app_number] => 13/273337 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4333 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083512.pdf [firstpage_image] =>[orig_patent_app_number] => 13273337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128571 [patent_doc_number] => 20120088829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Formulations of Ubiquinol and Resveratrol Esters' [patent_app_type] => utility [patent_app_number] => 13/248853 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15882 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088829.pdf [firstpage_image] =>[orig_patent_app_number] => 13248853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8749566 [patent_doc_number] => 08415399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Retrovirus-infection inhibitor' [patent_app_type] => utility [patent_app_number] => 13/246066 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 6698 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817468 [patent_doc_number] => 20120064088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHODS OF TREATING ANEURYSM' [patent_app_type] => utility [patent_app_number] => 13/229093 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6162 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064088.pdf [firstpage_image] =>[orig_patent_app_number] => 13229093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791601 [patent_doc_number] => 20120053157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM' [patent_app_type] => utility [patent_app_number] => 13/219030 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8123 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053157.pdf [firstpage_image] =>[orig_patent_app_number] => 13219030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135701 [patent_doc_number] => 20130296416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'SELECTIVE INHIBITION OF BETA1- ADRENERGIC RECEPTORS FOR THE TREATMENT OF PEDIATRIC HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/817969 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13079 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290458 [patent_doc_number] => 20120178787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'MELATONIN AND ITS USE IN PREVENTING POSTOPERATIVE COMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/209095 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4391 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13209095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8126655 [patent_doc_number] => 20120087876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA' [patent_app_type] => utility [patent_app_number] => 13/198599 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2433 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087876.pdf [firstpage_image] =>[orig_patent_app_number] => 13198599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892250 [patent_doc_number] => 20130165434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'COMPOSITION FOR CONTROLLING HARMFUL ARTHROPODS AND METHOD FOR CONTROLLING HARMFUL ARTHROPODS' [patent_app_type] => utility [patent_app_number] => 13/814946 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9507 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587395 [patent_doc_number] => 20110281905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/191911 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281905.pdf [firstpage_image] =>[orig_patent_app_number] => 13191911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778636 [patent_doc_number] => 20120041034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/187158 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041034.pdf [firstpage_image] =>[orig_patent_app_number] => 13187158 [rel_patent_id] =>[rel_patent_doc_number] =>)